Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rubika Balendra

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 19, 2022
Comparison Of King's Clinical Staging In Multinational Amyotrophic Lateral Sclerosis CohortsRubika Balendra, Ashley R Jones, Ahmad Al Khleifat, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 20, 2014
Health utility decreases with increasing clinical stage in amyotrophic lateral sclerosisAshley R Jones, Naheed Jivraj, Rubika Balendra, et al.
Life Science Alliance|July 12, 2023
Transcriptome-wide RNA binding analysis of C9orf72 poly(PR) dipeptidesRubika Balendra, Igor Ruiz de Los Mozos, Hana M Odeh, et al.
Nature Communications|December 13, 2023
The ALS/FTD-related C9orf72 hexanucleotide repeat expansion forms RNA condensates through multimolecular G-quadruplexesFederica Raguseo, Yiran Wang, Jessica Li, et al.
Neurobiology of Aging|April 17, 2013
Residual association at C9orf72 suggests an alternative amyotrophic lateral sclerosis-causing hexanucleotide repeatAshley R Jones, Ione Woollacott, Aleksey Shatunov, et al.
EMBO Molecular Medicine|November 9, 2017
G-quadruplex-binding small molecules ameliorate <i>C9orf72</i> FTD/ALS pathology <i>in vitro</i> and <i>in vivo</i>Roberto Simone, Rubika Balendra, Thomas G Moens, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 19, 2022
Comparison Of King's Clinical Staging In Multinational Amyotrophic Lateral Sclerosis CohortsRubika Balendra, Ashley R Jones, Ahmad Al Khleifat, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 20, 2014
Health utility decreases with increasing clinical stage in amyotrophic lateral sclerosisAshley R Jones, Naheed Jivraj, Rubika Balendra, et al.
Life Science Alliance|July 12, 2023
Transcriptome-wide RNA binding analysis of C9orf72 poly(PR) dipeptidesRubika Balendra, Igor Ruiz de Los Mozos, Hana M Odeh, et al.
Nature Communications|December 13, 2023
The ALS/FTD-related C9orf72 hexanucleotide repeat expansion forms RNA condensates through multimolecular G-quadruplexesFederica Raguseo, Yiran Wang, Jessica Li, et al.
Neurobiology of Aging|April 17, 2013
Residual association at C9orf72 suggests an alternative amyotrophic lateral sclerosis-causing hexanucleotide repeatAshley R Jones, Ione Woollacott, Aleksey Shatunov, et al.
EMBO Molecular Medicine|November 9, 2017
G-quadruplex-binding small molecules ameliorate <i>C9orf72</i> FTD/ALS pathology <i>in vitro</i> and <i>in vivo</i>Roberto Simone, Rubika Balendra, Thomas G Moens, et al.
Pageof 2